Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-077666

Options or other derivatives

  • Director acquired 1,077,756 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Alleva Lawrence M Director 2023-07-03 Grant or award · Option to purchase Ordinary Shares +1,077,756 1,077,756 D
Loading xslF345X04/tm2320409-3_4seq1.xml…